Gefitinib vs Moxifloxacin
Gefitinib vs Moxifloxacin: Overview
This comparison examines the pharmacological differences between Gefitinib and Moxifloxacin.
Mechanism of Action
Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pharmacokinetics
Half-life: Gefitinib β 48 hours; Moxifloxacin β 12 hours.
Chemical Properties
Molecular Formula: Gefitinib β C22H24ClFN4O3; Moxifloxacin β C21H24FN3O4.
Molecular Weight: Gefitinib β 446.9000 g/mol; Moxifloxacin β 401.4350 g/mol.
Type: Gefitinib β Small molecule; Moxifloxacin β Small molecule.